Planta Med 2010; 76 - P354
DOI: 10.1055/s-0030-1264652

New thymol derivatives and cytotoxic constituents from Eupatorium cannabinum subsp. asiaticum

JJ Chen 1, YC Tsai 1, PJ Sung 2, CC Ho 1
  • 1Department of Pharmacy & Graduate Institute of Pharmaceutical Technology, Tajen University, No. 20, Weishin Rd., Yanpu Shiang, Pingtung 907, Taiwan
  • 2National Museum of Marine Biology and Aquarium, Pingtung 944, Taiwan

Eupatorium cannabinum L. subsp. asiaticum Kitam (Compositae) is a perennial herb, distributed in Himalaya, China, and Taiwan [1]. Thymol derivatives [2], sesquiterpene lactones [3], diterpenes [4], flavonoids [4], pyrrolizidine alkaloids [4], and their derivatives are widely distributed in plants of genus Eupatorium. Many of these compounds exhibit anti-inflammatory, cytotoxic, and antibacterial activities [5]. Investigation on the n-hexane-soluble fraction of the aerial part of E. cannabinum subsp. asiaticum has led to the isolation of two new thymol derivatives, cannabithymol A (1) and cannabithymol B (2), together with five known compounds, including three thymol derivatives, (E)-2-methylbut-2-enolic acid 2-(2-acetoxymethyl-oxiranyl)-5-methyl-phenyl ester (3), 8-methoxy-9-O-angeloylthymol (4), and (Z)-3-acetoxy-2-hydeoxy-2-(2-hydroxy-4-methylphenol)propyl-2-ethylbut-2-enoate (5), a benzofuran, euparin (6), and a coumarin, 2H-chromen-2-one (7). The structures of the two new compounds were determined through spectral analyses including extensive 2D NMR data. Among the isolates, (E)-2-methylbut-2-enolic acid 2-(2-acetoxymethyl-oxiranyl)-5-methyl-phenyl ester (3) exhibited cytotoxic activity, with IC50 values of 0.02 and 1.02µg/mL, respectively, against DLD-1 and CCRF-CEM cell lines.

References: 1. Chang, C.E. et al. (1993) Compositae in Flora of Taiwan. 2nd edition. Editorial Committee of the Flora of Taiwan, Taipei, Taiwan. Vol. 2: 804–1101.

2. Tori M. et. al. (2001)J. Nat. Prod. 64: 1048–1051.

3. McPhail A.T. et al. (1975)J. Chem. Soc. Perkin II 1798–1801.

4. Paolini J. et al. (2007) Phytochem. Anal. 18: 235–244.

5. Woerdenbag, H.J. (1986) Pharm. Weekbl. Sci. 8: 245–251.